Clinical Trial Update: Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cilostazol plus Ginkgo biloba to improve cognitive function in elderly patients with type 2 diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Cilostazol (Cilostazol)
• Ginkgo biloba (Ginkgo biloba)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Type 2 Diabets Mellitus, Cognitive Ability, General | Phase 3 | Status: RECRUITING